Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006
- PMID: 17038465
- PMCID: PMC1798383
- DOI: 10.1136/ard.2006.061937
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006
Conflict of interest statement
Competing interests: none declared
References
-
- Furst D E, Breedveld F C, Kalden J R, Smolen J S, Burmester G R, Bijlsma J W.et al Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin‐1 receptor antagonist (IL‐1ra), for the treatment of rheumatic diseases, 2004. Ann Rheum Dis 200463(suppl 2)ii2–ii12. - PMC - PubMed
-
- Wolfe F, Pincus T, O'Dell J. Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy. J Rheumatol 2001281712–1717. - PubMed
-
- Gladman D D, Helliwell P, Mease P J, Nash P, Ritchlin C, Taylor W. Assessment of patients with psoriatic arthritis: a review of currently available measures. Arthritis Rheum 20045024–35. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources